4534 · Mochida Pharmaceutical Co.,Ltd. · Financials
Market Cap
117.84B JPY
Shares
35.12M
Volume · Nov 13
26.5K
Avg daily vol (3M)
44.74K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
116.95B
+11.2%
FY2026
Net Income
7.9B
+39%
FY2026
Gross Margin
48.11%
-3pp
FY2026
Operating Margin
8.68%
+1pp
FY2026
Operating Cash Flow
-7.35B
-178.6%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| JPY | 116.95B | 105.16B | 102.89B | 103.26B | 110.18B |
| JPY | 60.69B | 51.37B | 50.82B | 48.15B | 50.63B |
| JPY | 56.26B | 53.79B | 52.07B | 55.11B | 59.55B |
| JPY | 10.15B | 8.13B | 5.8B | 8.51B | 14.39B |
| JPY | 11.17B | 8.05B | 6.16B | 9.04B | 14.59B |
| JPY | 3.27B | 2.37B | 1.61B | 2.4B | 4.02B |
| JPY | 7.9B | 5.69B | 4.55B | 6.65B | 10.57B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 15.37B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.